[Federal Register Volume 84, Number 85 (Thursday, May 2, 2019)]
[Notices]
[Pages 18850-18851]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-08897]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Food and Drug Administration

[Docket No. FDA-2019-N-0001]


Preparation for International Cooperation on Cosmetics Regulation 
Thirteenth Annual Meeting; Public Meeting

AGENCY: Food and Drug Administration, HHS.

ACTION: Notice of public meeting.

-----------------------------------------------------------------------

SUMMARY: The Food and Drug Administration (FDA, the Agency, or we) is 
announcing the following public meeting entitled ``International 
Cooperation on Cosmetics Regulation (ICCR)--Preparation for ICCR-13 
Meeting.'' The purpose of the public meeting is to invite public input 
on various topics pertaining to the regulation of cosmetics. We may use 
this input to help us prepare for the ICCR-13 meeting that will be held 
July 9 to 11, 2019, in Montreal, Canada.

DATES: The public meeting will be held on June 5, 2019, from 2 p.m. to 
4 p.m. See the SUPPLEMENTARY INFORMATION section for registration date 
and information.

ADDRESSES: The public meeting will be held at the Food and Drug 
Administration, Center for Food Safety and Applied Nutrition, 5001 
Campus Dr., Wiley Auditorium (first floor), College Park, MD 20740.

FOR FURTHER INFORMATION CONTACT: Jonathan Hicks, Office of Cosmetics 
and Colors, Food and Drug Administration, 5001 Campus Dr. (HFS-125), 
College Park, MD 20740, 240-402-1375, Jonathan.Hicks@fda.hhs.gov.

SUPPLEMENTARY INFORMATION: 

I. Background

    The intention of the ICCR multilateral framework is to pave the way 
for the removal of regulatory obstacles to international trade while 
maintaining global consumer protection. The purpose of the meeting is 
to invite public input on various topics pertaining to the regulation 
of cosmetics. We may use this input to help us prepare for the ICCR-13 
meeting that will be held July 9 to 11, 2019, in Montreal, Canada.
    ICCR is a voluntary international group of cosmetics regulatory 
authorities from Brazil, Canada, the European Union, Japan, and the 
United States of America. These regulatory authority members will 
engage in constructive dialogue with their relevant cosmetics industry 
trade associations and public advocacy groups. Currently, the ICCR 
members are: The Brazilian Health Surveillance Agency; Health Canada; 
the European Commission Directorate-General for Internal Market, 
Industry, Entrepreneurship, and Small and Medium-sized Enterprises; the 
Ministry of Health, Labor, and Welfare of Japan; and FDA. All decisions 
are made by consensus and will be compatible with the laws, policies, 
rules, regulations, and directives of the respective administrations 
and governments. Members will implement and/or promote actions or 
documents within their own jurisdictions and seek convergence of 
regulatory policies and practices. Successful implementation will need 
input from stakeholders.

II. Topics for Discussion at the Public Meeting

    We will make the agenda for the public meeting available on the 
internet at https://www.fda.gov/Cosmetics/InternationalActivities/ICCR/default.htm. Depending on the number of requests for oral 
presentations, we intend to have an agenda available by May 29, 2019.

III. Participating in the Public Meeting

    Registration: To register for the public meeting, send registration 
information (including your name, title, affiliation, address, email, 
and telephone), to Jonathan Hicks by May 22, 2019. If you would like to 
listen to the meeting by phone, please submit a request for a dial-in 
number by May 22, 2019 (see FOR FURTHER INFORMATION CONTACT). If you 
need special accommodations due to a disability, please contact 
Jonathan Hicks by May 29, 2019.
    Requests for Oral Presentations: If you wish to present, you should 
notify Jonathan Hicks by May 22, 2019, and submit a brief statement of 
the general nature of the presentation: What you wish to present, your 
name, title, affiliation, address, email, and telephone, and indicate 
the approximate amount of time needed to make your presentation. You 
may wish to present proposals for future ICCR agenda items, data, 
information, or views, in person or in writing, on issues pending at 
the

[[Page 18851]]

public meeting or a topic related to a previous meeting. There will be 
no presentations by phone. Time allotted for oral presentations may be 
limited to 10 minutes or less for each presenter, depending on the 
number of requests received.
    Transcripts: Please be advised that as soon as a transcript of the 
public meeting is available, it will be accessible at https://www.regulations.gov. It may also be viewed at the Dockets Management 
Staff (HFA-305), Food and Drug Administration, 5630 Fishers Lane, Rm. 
1061, Rockville, MD 20850.

    Dated: April 26, 2019.
Lowell J. Schiller,
Principal Associate Commissioner for Policy.
[FR Doc. 2019-08897 Filed 5-1-19; 8:45 am]
 BILLING CODE 4164-01-P


